Browsing Section

Health

Expert Hails WHO Approval Of Newborn Malaria Drug

Ikotun Olayemi, President of the Nigeria Biochemistry Practitioners Association, says the recent approval by the World Health Organisation (WHO) of a newborn-specific malaria drug offers major biochemical and public health benefits for Nigeria. Olayemi made the remarks in an interview with the News Agency of Nigeria (NAN) on Wednesday in
Read More...